Top Page
Else Nutrition Holdings
(TSX:BABY)
Else Nutrition Holdings (BABY) vs. iShares MSCI Canada ETF (EWC)
Else Nutrition Holdings Business Overview & Revenue Model
Else Nutrition Holdings Earnings Call Summary
Else Nutrition Holdings Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.80M | 7.97M | 9.36M | 8.53M | 4.69M | 1.48M |
| Gross Profit | -2.89M | -5.64M | -85.00K | 1.31M | 743.00K | 498.00K |
| EBITDA | -11.50M | -14.78M | -15.17M | -17.12M | -1.23M | -23.91M |
| Net Income | -12.04M | -15.18M | -15.61M | -17.61M | -1.62M | -24.10M |
Balance Sheet | ||||||
| Total Assets | 4.82M | 7.56M | 16.07M | 26.16M | 32.92M | 29.32M |
| Cash, Cash Equivalents and Short-Term Investments | 87.00K | 103.00K | 4.92M | 15.38M | 24.28M | 24.71M |
| Total Debt | 918.00K | 874.00K | 5.53M | 3.37M | 941.00K | 228.00K |
| Total Liabilities | 5.51M | 5.80M | 9.35M | 10.57M | 6.15M | 18.11M |
| Stockholders Equity | -691.00K | 1.75M | 6.72M | 15.60M | 26.77M | 11.21M |
Cash Flow | ||||||
| Free Cash Flow | -6.70M | -9.12M | -18.31M | -21.07M | -16.05M | -9.82M |
| Operating Cash Flow | -6.70M | -9.06M | -18.31M | -20.91M | -15.76M | -9.59M |
| Investing Cash Flow | 625.00K | 2.71M | -1.13M | 170.00K | 1.14M | -3.93M |
| Financing Cash Flow | 4.18M | 3.73M | 7.44M | 11.69M | 16.85M | 32.45M |
Else Nutrition Holdings Technical Analysis
Else Nutrition Holdings Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
45 Neutral | $7.86M | ― | -517.87% | ― | -25.08% | 65.57% | |
44 Neutral | C$4.33M | -0.97 | -70.53% | ― | -41.18% | 17.65% | |
33 Underperform | C$1.41M | -0.20 | -190.55% | ― | ― | -126.28% | |
27 Underperform | C$6.06M | -2.93 | -86.40% | ― | -49.04% | 15.60% |
Else Nutrition Holdings Corporate Events
Else Nutrition Holdings Inc. has entered into a convertible security funding agreement with Lind Global Fund III LP, managed by The Lind Partners, LLC, to raise up to US$1,280,000. The initial funding of US$420,000 will be used for production and working capital, with the potential for three additional follow-on investments. The Toronto Stock Exchange has conditionally approved the listing of additional shares, which will be subject to certain trading restrictions.
Else Nutrition Holdings Inc. has announced a significant legislative breakthrough as the U.S. Government’s new budget, signed by President Trump, includes directives to streamline FDA regulatory pathways for plant-based, non-soy, non-dairy infant formulas. This development, facilitated by Else’s Government Affairs initiatives, marks a pivotal moment for the company, enabling it to accelerate its engagement with federal regulators and expand its product offerings in the U.S. market. The legislative change is expected to enhance consumer choice and nutritional equity for American families, particularly those seeking alternatives due to allergies, intolerances, or lifestyle preferences.
Else Nutrition Holdings Inc. is a company focused on developing innovative, clean, and plant-based nutrition products for infants, toddlers, children, and adults, offering a unique alternative to traditional dairy-based formulas.
Else Nutrition Holdings reported a significant operational turnaround in Q3 2025, highlighted by a gross profit margin increase to 34% and a 68% reduction in operating expenses. The company achieved a reduction in operating loss and trade payables, indicating improved financial sustainability. Despite a slight revenue dip due to temporary out-of-stock issues, Else Nutrition is actively addressing supply chain challenges and expanding its retail and online presence. The company is preparing for the next clinical phase of its plant-based infant formula and is engaged in strategic collaborations, reinforcing its position as a pioneer in plant-based nutrition.
Else Nutrition Holdings Inc. announced the rescheduling of its third-quarter business update conference call to November 17, 2025. The company will discuss financial results and corporate progress, impacting its operations and industry positioning as it continues to expand its plant-based nutrition offerings.
Else Nutrition Holdings Inc. has announced a business update conference call scheduled for November 18, 2025, to discuss its third-quarter financial results and corporate developments. This announcement is significant for stakeholders as it provides insights into the company’s financial health and strategic progress, potentially impacting its market positioning and investor confidence.
Else Nutrition Holdings Inc. announced a consolidation of its common shares, reducing the number of issued shares from approximately 374 million to 37 million. This strategic move aims to enhance the company’s stock market presence and streamline its share structure, potentially impacting its market positioning and shareholder value.
Else Nutrition Holdings Inc. is a food and nutrition company focused on developing innovative, plant-based products for infants, toddlers, children, and adults, offering a clean-ingredient alternative to traditional dairy-based formulas.
Else Nutrition Holdings Inc. recently held its earnings call, revealing a mixed sentiment. The company has made strides in cost reduction and operational efficiency, alongside promising regulatory and international growth opportunities. However, challenges such as declining revenue, negative gross margins, and inventory constraints have posed significant hurdles.
Else Nutrition Holdings Inc. reported its 2025 second quarter financial results, highlighting steady progress despite macroeconomic pressures and funding constraints. The company faced temporary inventory constraints, impacting revenue and gross profit, but remains optimistic about future growth with regulatory advancements in the U.S. and plans to optimize its supply chain. Operating expenses were significantly reduced, and the company is in talks with multinational companies for distribution and R&D collaborations, aiming for cash-flow positivity by late 2026 or early 2027.
Else Nutrition Holdings Inc. announced a business update conference call scheduled for September 16, 2025, to discuss its financial results for the second quarter of 2025 and corporate progress. This announcement highlights the company’s ongoing efforts to maintain transparency with stakeholders and its commitment to growth in the plant-based nutrition industry.
Else Nutrition Holdings Inc. announced a business update conference call scheduled for September 16, 2025, to discuss its financial results for the second quarter of 2025 and corporate progress. This announcement highlights the company’s ongoing efforts to maintain transparency with stakeholders and its commitment to growth in the plant-based nutrition industry.